Candace Wu1, Avinainder Singh1, Bradley Collins1, Amber Fatima1, Arman Qamar2, Ankur Gupta1, Jon Hainer1, Josh Klein1, Petr Jarolim3, Marcelo Di Carli1, Khurram Nasir4, Deepak L Bhatt2, Ron Blankstein5. 1. Cardiovascular Imaging Program, Departments of Medicine and Radiology, Harvard Medical School, Boston, Mass. 2. Cardiovascular Division, Department of Medicine, Harvard Medical School, Boston, Mass. 3. Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass. 4. Miami Cardiac and Vascular Institute, Baptist Health South Florida, Miami, Fla. 5. Cardiovascular Imaging Program, Departments of Medicine and Radiology, Harvard Medical School, Boston, Mass. Electronic address: rblankstein@bwh.harvard.edu.
Abstract
BACKGROUND: While increased serum troponin levels are often due to myocardial infarction, increased levels may also be found in a variety of other clinical scenarios. Although these causes of troponin elevation have been characterized in several studies in older adults, they have not been well characterized in younger individuals. METHODS: We conducted a retrospective review of patients 50 years of age or younger who presented with elevated serum troponin levels to 2 large tertiary care centers between January 2000 and April 2016. Patients with prior known coronary artery disease were excluded. The cause of troponin elevation was adjudicated via review of electronic medical records. All-cause death was determined using the Social Security Administration's death master file. RESULTS: Of the 6081 cases meeting inclusion criteria, 3574 (58.8%) patients had a myocardial infarction, while 2507 (41.2%) had another cause of troponin elevation. Over a median follow-up of 8.7 years, all-cause mortality was higher in patients with nonmyocardial infarction causes of troponin elevation compared with those with myocardial infarction (adjusted hazard ratio [HR] 1.30; 95% confidence interval [CI], 1.15-1.46; P < .001). Specifically, mortality was higher in those with central nervous system pathologies (adjusted HR 2.21; 95% CI, 1.85-2.63; P < .001), nonischemic cardiomyopathies (adjusted HR 1.66; 95% CI, 1.37-2.02; P < .001), and end-stage renal disease (adjusted HR 1.36; 95% CI, 1.07-1.73; P = .013). However, mortality was lower in patients with myocarditis compared with those with an acute myocardial infarction (adjusted HR 0.43; 95% CI:, 0.31-0.59; P < .001). CONCLUSION: There is a broad differential for troponin elevation in young patients, which differs based on demographic features. Most nonmyocardial infarction causes of troponin elevation are associated with higher all-cause mortality compared with acute myocardial infarction.
BACKGROUND: While increased serum troponin levels are often due to myocardial infarction, increased levels may also be found in a variety of other clinical scenarios. Although these causes of troponin elevation have been characterized in several studies in older adults, they have not been well characterized in younger individuals. METHODS: We conducted a retrospective review of patients 50 years of age or younger who presented with elevated serum troponin levels to 2 large tertiary care centers between January 2000 and April 2016. Patients with prior known coronary artery disease were excluded. The cause of troponin elevation was adjudicated via review of electronic medical records. All-cause death was determined using the Social Security Administration's death master file. RESULTS: Of the 6081 cases meeting inclusion criteria, 3574 (58.8%) patients had a myocardial infarction, while 2507 (41.2%) had another cause of troponin elevation. Over a median follow-up of 8.7 years, all-cause mortality was higher in patients with nonmyocardial infarction causes of troponin elevation compared with those with myocardial infarction (adjusted hazard ratio [HR] 1.30; 95% confidence interval [CI], 1.15-1.46; P < .001). Specifically, mortality was higher in those with central nervous system pathologies (adjusted HR 2.21; 95% CI, 1.85-2.63; P < .001), nonischemic cardiomyopathies (adjusted HR 1.66; 95% CI, 1.37-2.02; P < .001), and end-stage renal disease (adjusted HR 1.36; 95% CI, 1.07-1.73; P = .013). However, mortality was lower in patients with myocarditis compared with those with an acute myocardial infarction (adjusted HR 0.43; 95% CI:, 0.31-0.59; P < .001). CONCLUSION: There is a broad differential for troponin elevation in young patients, which differs based on demographic features. Most nonmyocardial infarction causes of troponin elevation are associated with higher all-cause mortality compared with acute myocardial infarction.
Authors: Ziad Hijazi; Jonas Oldgren; Ulrika Andersson; Stuart J Connolly; Michael D Ezekowitz; Stefan H Hohnloser; Paul A Reilly; Dragos Vinereanu; Agneta Siegbahn; Salim Yusuf; Lars Wallentin Journal: Circulation Date: 2012-02-28 Impact factor: 29.690
Authors: Hanna K Gaggin; Yuyin Liu; Asya Lyass; Roland R J van Kimmenade; Shweta R Motiwala; Noreen P Kelly; Aditi Mallick; Parul U Gandhi; Nasrien E Ibrahim; Mandy L Simon; Anju Bhardwaj; Arianna M Belcher; Jamie E Harisiades; Joseph M Massaro; Ralph B D'Agostino; James L Januzzi Journal: Circulation Date: 2016-11-21 Impact factor: 29.690
Authors: Sripal Bangalore; Gregg C Fonarow; Eric D Peterson; Anne S Hellkamp; Adrian F Hernandez; Warren Laskey; W Frank Peacock; Christopher P Cannon; Lee H Schwamm; Deepak L Bhatt Journal: Am J Med Date: 2012-06-27 Impact factor: 4.965
Authors: Brendan M Everett; Maria Mori Brooks; Helen E A Vlachos; Bernard R Chaitman; Robert L Frye; Deepak L Bhatt Journal: N Engl J Med Date: 2015-08-13 Impact factor: 91.245
Authors: Benjamin J Freda; W H Wilson Tang; Frederick Van Lente; W Franklin Peacock; Gary S Francis Journal: J Am Coll Cardiol Date: 2002-12-18 Impact factor: 24.094
Authors: Benjamin M Scirica; Deepak L Bhatt; Eugene Braunwald; Itamar Raz; Matthew A Cavender; KyungAh Im; Ofri Mosenzon; Jacob A Udell; Boaz Hirshberg; Pia S Pollack; Ph Gabriel Steg; Petr Jarolim; David A Morrow Journal: JAMA Cardiol Date: 2016-12-01 Impact factor: 14.676
Authors: Michael J Coronado; Katelyn A Bruno; Lori A Blauwet; Carsten Tschöpe; Madeleine W Cunningham; Sabine Pankuweit; Sophie van Linthout; Eun-Seok Jeon; Dennis M McNamara; Jan Krejčí; Julie Bienertová-Vašků; Erika J Douglass; Eric D Abston; Adriana Bucek; J Augusto Frisancho; Merci S Greenaway; Anneliese R Hill; Heinz-Peter Schultheiss; Leslie T Cooper; DeLisa Fairweather Journal: J Am Heart Assoc Date: 2019-01-22 Impact factor: 5.501
Authors: Sheharyar Raza; Andre C Amaral; Jeffrey Pang; Fuad Moussa; Dominick Shelton; Lowyl Notario; Heather Harrington; Jeannie L Callum; Paul M Yip Journal: BMJ Open Qual Date: 2020-12
Authors: Pegah Khaloo; Ayman Shaqdan; Pablo A Ledesma; Uwajachukwumma A Uzomah; Jennifer Galvin; Leon M Ptaszek; Jeremy N Ruskin Journal: Int J Cardiol Date: 2021-12-21 Impact factor: 4.039